LCI 1353 2 (Hydromorphone 2 mg)
Pill imprint LCI 1353 2 has been identified as Hydromorphone hydrochloride 2 mg.
Hydromorphone is used in the treatment of chronic pain; pain; cough; anesthetic adjunct and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Hydromorphone 2 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
- LCI 1353 2
- 2 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Lannett Company, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
|NDC Code||Manufacturer / Repackager|
|68084-0423||Amerisource Health Services|
|54868-3165||Physicians Total Care Inc (repackager)|
|43063-0051||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about hydromorphone
- Hydromorphone extended-release capsules
- Hydromorphone high-potency
- Hydromorphone liquid
- Hydromorphone suppository
- More (5) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.